For Residents

A Starter Guide to Immunofluorescence Testing in Dermatology

Author and Disclosure Information

 

References

Where Should I Biopsy?

Knowing where to biopsy can be confusing when beginning residency. But the short answer is, it depends. Let your clinical suspicion guide your specimen site. The Figure provides a quick reference for which location will give you the highest yield for a specific diagnosis.

Preferred sites for biopsy specimens for direct immunofluorescence (DIF) in autoimmune bullous disorders. BP indicates bullous pemphigoid; DH, dermatitis herpetiformis.

A few cardinal rules should guide which site is biopsied. Avoid obtaining specimens from the lower extremities as much as possible, as this site has been linked with false-negative results, especially in bullous pemphigoid.19,20 As a dependent area prone to stasis, this site gets a lot of abuse and inflammatory changes secondary to everyday insults that can theoretically alter DIF findings, especially fibrinogen deposition.

Although tissue sent for hematoxylin and eosin staining should be lesional, biopsy for DIF ideally should not contain a new or active blister, ulcer, erosion, or bulla. Immunoreactants are more likely to be degraded in these areas, and DIF may be falsely negative.21

It is worthwhile to briefly discuss the definitions of the terms perilesional and nonlesional. Perilesional skin most frequently refers to skin adjacent to a bulla or vesicle. This skin can be erythematous/inflamed or appear normal. When obtaining tissue for a diagnosis of blistering disease, the general recommendation is to obtain the biopsy from lesional nonbullous skin or perilesional uninvolved skin within 1 cm of the bulla.22-24 The only exception to this is dermatitis herpetiformis, which is best diagnosed on tissue obtained from normal-appearing perilesional skin within 1 cm of an active lesion.25 Additionally, if your patient has oral disease, the recommendation is to obtain the biopsy from nonlesional buccal mucosa, especially if there is desquamative gingivitis.26,27

The ideal biopsy size is 4 or 5 mm. If considering both DIF and histopathology, it is best to procure 2 separate specimens. One larger biopsy can be carefully bisected in 2 but often is subject to more handling artifacts, which can affect findings. In the case of 1 biopsy bisected into 2 specimens, the punch should be at least 6 mm. Shave biopsies also can be performed as long as they extend into the reticular dermis.23

Recommended Reading

Erythematous and Ulcerated Plaque on the Left Temple
MDedge Dermatology
Pedunculated Tumor on the Posterior Neck
MDedge Dermatology
Bullous Amyloidosis Masquerading as Pseudoporphyria
MDedge Dermatology
Painful Psoriasiform Plaques
MDedge Dermatology
Soft Nodule on the Forearm
MDedge Dermatology
Tender Annular Plaque on the Thigh
MDedge Dermatology
Early Pilomatrix Carcinoma: A Case Report With Emphasis on Molecular Pathology and Review of the Literature
MDedge Dermatology
Advocacy Update: Is Your Practice Equipped to Handle Looming Changes in Dermatopathology?
MDedge Dermatology
Firm Digital Papulonodules in an Infant
MDedge Dermatology
Erythematous Nodule With Central Erosions on the Calf
MDedge Dermatology